Tracking the landscape of patent remedies
 
Causal nexus found where Defendant couldn’t achieve ANDA product without infringing

Causal nexus found where Defendant couldn’t achieve ANDA product without infringing

Mylan v. Aurobindo was decided on May 19, 2017 on appeal from the Eastern District of Texas. There, the district court granted co-Plaintiff Mylan’s motion for a preliminary injunction as to the compound and process patents, finding that Defendant Aurobindo likely infringed the patents under the doctrine of equivalents, and that Arubindo didn’t raise a substantial question of validity. The district court found that co-Plaintiff Apicore would be irreparably harmed through lost sales, lost R&D, price erosion, and the fact of direct competition with an infringer. Aurobindo appealed the injunction grant.

The Federal Circuit reversed the grant of injunction as to the process patents, and affirmed as to the compound patent.

The district court erred in granting the preliminary injunction as to the process patents because Aurobindo raised a substantial question of infringement under the doctrine of equivalents.

The district court didn’t err in granting the injunction as to the compound patent. Arubindo didn’t raise a substantial question as to the patent’s validity.

The Federal Circuit affirmed the irreparable harm finding. There was record evidence that Apicore had, and would continue to “suffer from lost sales, lost research and development, price erosion, and having to directly compete with an infringer.” There was a causal nexus because Aurobindo couldn’t achieve the product purity described in its ANDA without infringing the process and compound patents, and thus its generic drug wouldn’t be on the market “if it had not obtained FDA approval for a product that will likely be found to be covered by the patents.”

Because Aurobindo didn’t challenge the balance of the equity or the public interest factors, the preliminary injunction grant was affirmed as to the compound patent.

 

Mylan Institutional LLC v. Aurobindo Pharma Ltd., 857 F.3d 858 (Fed. Cir. 2017)

Causes of weak erection: Cardiovascular issues, hormonal inefficiency, psychological as well as painkillers effect are some of the primary causes of weak erection include too much pressure at work, anxiety, fear, reduced levitra sale testosterone and alcohol consumption. It is the only medication which not only acts fast but also includes that extra punch for you to go on for 5 hours! So 5mg cialis online the next time you think to start the treatment. The pill helps achieve excitement with your wife during an intimacy. achat viagra pfizer Once other conditions have been ruled out only then can IBS be diagnosed. viagra generika obtain at website